LEVORA SUMMARY
WATSON PHARMA
Revised: May 2005
IN-5262/S
PHYSICIAN LABELING
Levora ® 0.15/30-28
(levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/0.03 mg)
Rx only
Levora ® 0.15/30-28 Tablets provide an oral contraceptive regimen consisting of 21 white tablets containing levonorgestrel 0.15 mg and ethinyl estradiol 0.03 mg followed by 7 peach tablets containing inert ingredients. Levonorgestrel is a totally synthetic progestogen with the chemical name (–)-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one. Ethinyl estradiol is an estrogen with the chemical name 19-Nor-17α-pregna-1,3,5(10)-trien-20-yne-3,17-diol.
Oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.
|
|
NEWS HIGHLIGHTSMedia Articles Related to Levora (Levonorgestrel / Estradiol)
'15 million unwanted pregnancies' created by low contraception in 35 poorer countries
Source: Abortion News From Medical News Today [2015.02.05]
Some 90% of the 16.7 million unwanted pregnancies across a third of the world's population every year are due to a failure to use modern contraception, study suggests.
Research reveals more than half of young women who have abortions were using contraception when they fell pregnant
Source: Abortion News From Medical News Today [2014.04.30]
Reproductive health charity Marie Stopes UK has launched the findings of the first research in the UK into the contraceptive use of women aged 16-24 having one or more abortions.
Study shows Mirena (LNG-IUS 52mg) significantly more effective than copper IUD in preventing pregnancy
Source: Sexual Health / STDs News From Medical News Today [2015.02.04]
A study, published online in the journal of Contraception, concludes that while both Mirena and copper intrauterine devices (Cu-IUD) are highly effective methods - with Pearl Indices of 0.
Contraceptive study seeks to reduce unintended pregnancies, Australia
Source: Medical Students / Training News From Medical News Today [2015.01.16]
A major four-year trial will offer GPs across Victoria specialised training on contraception to reduce the number of unintended pregnancies by increasing uptake of Long Acting Reversible...
New research shows a statistical significant association between increased LARC usage and reduction in teenage pregnancy and abortion rates in England
Source: Abortion News From Medical News Today [2014.11.27]
New findings, published in the International Journal of Women's Health, show increased long-acting reversible contraception (LARC) usage in England was significantly associated with decreased...
Clinical Trials Related to Levora (Levonorgestrel / Estradiol)
Effects of Administration of Fostamatinib on Blood Concentrations of an Oral Contraceptive in Healthy Female Subjects [Recruiting]
A crossover study to assess the effect of repeated doses of fostamatinib on the levels of
oral contraceptive (Microgynon® 30) in the blood of healthy female subjects. The study will
consist of a screening period of up to 35 days, followed by 2 treatment periods (28 days
each) of an oral contraceptive (Microgynon® 30) in the absence and presence of fostamatinib.
The study will also evaluate the safety and tolerability of fostamatinib in combination
with an oral contraceptive
AZD6140 Oral Contraceptive Interaction Study [Recruiting]
A Study to Investigate the Potential Pharmacokinetic Interaction of Perampanel With Oral Contraceptives in Healthy Female Subjects [Recruiting]
A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil. [Completed]
The purpose of the study was to compare the contraceptive efficacy and safety of the
transdermal patch to Triphasil.
A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens [Completed]
This is a randomized, open-label study to evaluate pituitary ovarian suppression in healthy,
reproductive-aged women using three different regimens of oral contraceptives (OCs). Two
extended regimen OCs, Seasonale (levonorgestrel/ethinyl estradiol 0. 15/0. 03 mg for 84 days
followed by 7 days of placebo), and Seasonique (levonorgestrel/ethinyl estradiol 0. 15/0. 03 mg
for 84 days followed by 7 days of ethinyl estradiol 0. 01 mg), and a 28-day regimen OC, Portia
(levonorgestrel/ethinyl estradiol 0. 15/0. 03 mg for 21 days followed by 7 days of placebo).
|
PATIENT REVIEWS / RATINGS / COMMENTSBased on a total of 2 ratings/reviews, Levora has an overall score of 8.50. The effectiveness score is 10 and the side effect score is 7. The scores are on ten point scale: 10 - best, 1 - worst.
| | Levora review by 31 year old female patient | | | Rating |
| Overall rating: | |  |
| Effectiveness: | | Highly Effective |
| Side effects: | | Mild Side Effects | | |
Treatment Info |
| Condition / reason: | | Birth Control Pill |
| Dosage & duration: | | .15/.03 (dosage frequency: daily) for the period of 5 years |
| Other conditions: | | Irregular Menstrual Cycles, Painful Menstruations |
| Other drugs taken: | | none | | |
Reported Results |
| Benefits: | | The pills regulated my menstrual cycle and reduced the occurance of cramps (so severe that I was often bed ridden). Other birth control pills that I had taken previously had undesirable side effects, such as weight gain, which I have not experienced with Levora. |
| Side effects: | | I have headaches, and occasionally migraines, during my menstruation. |
| Comments: | | One pill, once a day, preferably around the same time. |
|
| | Levora review by 28 year old female patient | | | Rating |
| Overall rating: | |  |
| Effectiveness: | | Highly Effective |
| Side effects: | | Moderate Side Effects | | |
Treatment Info |
| Condition / reason: | | Contraception |
| Dosage & duration: | | one pill a day taken 4 months and then 1 week of placebo for the period of 1 year |
| Other conditions: | | none |
| Other drugs taken: | | none | | |
Reported Results |
| Benefits: | | protection against pregnancy. |
| Side effects: | | decreased vaginal lubrication and sex drive |
| Comments: | | I take the pill continuously, skipping the placebos and thus my period for four months, followed by one week of placebos. My mood, energy and hormonal balance remain constant, particularly compared to other pills but unfortunately so has my sex drive. The changes in sexual feelings are clearly related to the pill because as soon as I take the placebos I experience a huge elevation in sex drive. That is not much motivation to keep taking them but aside from spermicidal barrier methods that cause irritation and invasive procedures such as the IUD, I don't know what other options I have. |
|
|
|
Page last updated: 2015-02-05
|
